Last updated on October 1, 2025
Germany permits patients to import certain cannabis‑based medicinal products for personal therapeutic use only under strict conditions: the patient must hold a valid medical prescription from a German physician and, where required, obtain an import authorisation from the Federal Institute for Drugs and Medical Devices (BfArM). Products must comply with German pharmaceutical standards and be sourced from authorised suppliers; quantities authorised are typically limited to what is necessary for the prescribed treatment period. Patients who are legal residents and registered with the statutory health system may apply for cost coverage under exceptional medical necessity rules, but private importation without authorisation risks seizure and regulatory penalties. Exporting or bringing unlicensed recreational cannabis into Germany remains illegal and is prosecuted under narcotics law. Patients should consult BfArM guidance and their prescribing doctor before arranging cross‑border supply.
https://www.bfarm.de/EN/Home/home_node.html
7/3/2024